Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
NEW YORK & MAINZ, Germany--(BUSINESS WIRE) February 17, 2021 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an a
Pfizer Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab (PF-06863135) in Multiple Myeloma
NEW YORK--(BUSINESS WIRE)-- February 17, 2021 -- Pfizer Inc. (NYSE:PFE) today announced that the first participant has been dosed in the registration-enabling Phase 2 MagnetisMM-3 study (NCT04649359)
FDA Grants Sotorasib Priority Review Designation For The Treatment Of Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
THOUSAND OAKS, Calif., Feb. 16, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review for sotorasib for the treatment of
Johnson & Johnson Announces Submission of European Conditional Marketing Authorisation Application to the EMA for its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate
NEW BRUNSWICK, N.J., February 16, 2021 -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced that Janssen-Cilag International N.V., has submitted a conditional Marketing Authorisation App
Moderna Provides U.S. COVID-19 Vaccine Supply Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 16, 2021 -- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided a supply update for
AstraZeneca COVID-19 Vaccine Authorised for Emergency Use by the World Health Organization
15 February 2021 -- AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 yea
Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea
GAITHERSBURG, Md., Feb. 15, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, and SK Bioscience, a vac
Sputnik V Authorized in 26 Countries
Moscow, February 12, 2021 -- The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of Russian Sputnik V vaccine against coronavirus in Montenegro and Saint V
Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
NEW YORK and MAINZ, GERMANY, February 12, 2021 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government has exercised its option for an additional 100 million
Canada Purchases Additional 4 Million Doses of Moderna’s COVID-19 Vaccine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 12, 2021 -- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Canadian G
Four Potential COVID-19 Therapeutics Enter Phase 2/3 Testing in NIH ACTIV-2 Trial
February 12, 2021 -- Enrollment has begun to test additional investigational drugs in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) program. ACTIV is a public-private partne
Qatar Ministry of Public Health Issues Emergency Use Authorization for COVID-19 Vaccine Moderna
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 11, 2021 -- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Qatar Mini
News
- CLINIEXPERT -
Int'l Clinical Service Expert
We are the leader
Because of our professionism
